Skip to main content

Distinguished Speaker Series | Lu Chen

-
Location
https://ucihealth.zoom.us/j/92801383742?pwd=vfI4WBKGwibdfbtyznYWvAbSg3CccO.1
Event Type

Add to Calendar: Outlook | Google | iCal

The Center for Translational Vision Research Distinguished Speaker Series, also known as "Friday Seminars" showcases innovative research across the world. The seminar series has now been expanded to include lectures by experts on topics ranging from Ophthalmology, Genetics, Biochemistry, Neurobiology, Imaging, Computational Sciences to Novel Ophthalmic Treatments.

All talks are hybrid. You can join us in person at

The Falling Leaves Foundation Building, Main Entrance Level

Conference Room (2nd Floor by signage)

847 Health Sciences Quad

You can also join us by zoom. Zoom link and information are on your right and in the calendar links above.

January 23, 2026 | Lu Chen, PhD

Novel insights into ocular lymphatics

 

Learn More About the Distinguished Speaker Series

Featured


Lu Chen, MD, PhD
Lu Chen, MD, PhD
  • Lu Chen, MD, PhD, Professor, Vision Science Program, and Herbert Wertheim School of Optometry & Vision Science, University of California at Berkeley

Dr. Lu Chen, M.D., Ph.D., FARVO, is a Professor of Vision Science and Optometry in the Vision Science Graduate Program at the UC Berkeley School of Optometry and a member of the Center for Eye Disease & Development. With training as both a physician and a scientist, her work bridges clinical ophthalmology and basic vision research, focusing on the molecular and cellular mechanisms that regulate ocular blood and lymphatic vessels. Dr. Chen’s research has made significant contributions to understanding ocular lymphatic biology, including the development and function of lymphatic pathways in the cornea, conjunctiva, and Schlemm’s canal. Her laboratory examines how vascular and immune systems interact to influence inflammation, fluid homeostasis, and glaucoma, with implications for corneal disease and transplant rejection. Using genetic, molecular, and advanced imaging approaches, her work aims to identify new biological targets for therapies that protect and preserve vision.